Delaware reports a zero life sciences real estate vacancy rate

May 26, 2026 - 02:44

Delaware has reached a striking milestone in its commercial real estate market, with the vacancy rate for life sciences properties dropping to zero percent during the first quarter of this year. The figure, reported by real estate services firm CBRE, highlights an intense demand for lab and research space across the state.

The zero vacancy rate means that every available square foot of life sciences real estate is currently occupied, leaving no room for immediate move-ins. This tight market reflects a broader trend in the region, where pharmaceutical and biotech companies are aggressively expanding their footprints. Delaware's proximity to major research hubs, combined with a business-friendly tax environment, has made it an attractive location for firms specializing in drug development and medical technology.

Industry analysts suggest that the lack of available space could drive up rental prices and spur new construction projects. Developers are reportedly scouting sites in areas like Newark and Wilmington to meet the growing demand. However, the timeline for new buildings remains uncertain, as construction costs and zoning approvals can slow progress.

For now, companies looking to establish or expand operations in Delaware may face significant challenges securing a location. The zero vacancy rate underscores the state's emergence as a key player in the life sciences sector, but it also signals a pressing need for additional infrastructure to sustain future growth.